NXPL NextPlat Corp
$9.00▼ -1.04%
Technology
Other
After hours
$9.00▲ +0.33%
Sep 11, 4:10 PM ET
Volume 3.0K
Avg Volume (10D) 41.1K
Key Metrics & Fundamentals
Market Cap
$24.42M
P/E Ratio
–
Div Yield
–%
52W Range
3.40 - 11.10
% vs 50 MA
20.86%
% vs 200 MA
42.04%
RSI-14
60.0
MACD Histogram
-0.1200
Beta (1Y vs SPY)
1.83
Free Cash Flow
$1.09M
Gross Rev
$11.88M
Gross Profit
$4.69M
EBITDA
$16,000
COGS
$7.19M
Operating Exp
$4.82M
Operating Income
-$127,000
EBIT
-$127,000
Pretax Income
-$96,000
Net Income
-$144,000
EPS (Diluted)
-0.05
Price & Volume History
Loading chart…
Recent News
NextPlat Corp (NXPL) (Q2 2026) Earnings Call Highlights: Record Margins and Strategic Shift ...
GuruFocus.com · Aug 13, 2026 11:07 PM
NextPlat Reports 21% Sequential Quarterly Revenue Growth, 87% Reduction in Quarterly Net Loss to $144,000 and Record Gross Margin of Approximately 40%
PR Newswire · Aug 13, 2026 12:01 PM
NextPlat to Release Second Quarter 2026 Results on Thursday, August 13, 2026
PR Newswire · Aug 3, 2026 12:01 PM
NextPlat Delivers Mid-Year 2026 Shareholder Update Confirming Strong Growth and Profitability Outlook
PR Newswire · Jul 28, 2026 12:05 PM
NextPlat's PharmcoRx Earns NABP Specialty Pharmacy Accreditation Strengthening its Credentials for New Opportunities with Healthcare Institutions and Providers
PR Newswire · Jul 20, 2026 12:01 PM
NextPlat to Acquire Pensacola-Area Pharmacy, Expanding Florida Footprint and Adding Approximately $5.6 Million in Profitable Annual Revenue
PR Newswire · Jul 15, 2026 12:03 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See NXPL's money flow as a full page
Social Sentiment
Avg +0.90 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.